Gastric (Stomach) Cancer clinical trials at UC Irvine
1 research study open to eligible people
Showing trials for
Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial
open to eligible people ages 18 years and up
This is a phase II single-arm, Phase 2a, randomized, double-blinded, placebo-controlled pilot clinical trial determining efficacy of riluzole in preventing cognitive dysfunction in subjects with cancer, who are receiving chemotherapy.
Orange, California
Our lead scientists for Gastric (Stomach) Cancer research studies include Alexandre Chan.
Last updated: